• Hangzhou Diagens Biotechnology held its first extraordinary general meeting on July 23, 2026.
• Shareholders adopted amendments to the articles of association tied to an adjustment of the company’s business scope.
• The vote authorized the changes; the announcement did not confirm implementation steps had been completed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Diagens Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260723-12254248), on July 23, 2026, and is solely responsible for the information contained therein.